Sitagliptin Use in Patients With Diabetes and Heart Failure
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference35 articles.
1. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review;Eurich;BMJ,2007
2. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada;Can J Diabetes,2008
3. Summary of revisions for the 2013 clinical practice recommendations;Diabetes Care,2013
4. Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure;Gomez;Eur J Heart Fail,2012
5. Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms;Picatoste;PLoS One,2013
Cited by 108 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diabetes and Heart Failure: A Literature Review, Reflection and Outlook;Biomedicines;2024-07-15
2. Targeting autophagy in diabetic cardiomyopathy: From molecular mechanisms to pharmacotherapy;Biomedicine & Pharmacotherapy;2024-06
3. Re-evaluation of dipeptidyl peptidase-4 inhibitors in patients with heart failure and diabetes mellitus;Diabetes Research and Clinical Practice;2023-08
4. DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature;Frontiers in Molecular Biosciences;2023-05-23
5. Heart failure and diabetes: Clinical significance and epidemiology of this two‐way association;Diabetes, Obesity and Metabolism;2023-04-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3